Drug intelligence / Profile preview

Canglob D Forte

Development stage
Unknown
Lead developer
Dyntec
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intramuscular, Intravenous
01

Overview

Canglob D Forte is a veterinary biological product developed by Dyntec for the passive immunization of dogs against canine distemper. It consists of a purified hyperimmune globulin fraction (immunoglobulins) obtained from the blood of hyperimmunized dogs. Unlike active vaccines that stimulate the animal's own immune system to produce antibodies over time, Canglob D Forte provides immediate, pre-formed antibodies that specifically neutralize the Canine Distemper Virus (CDV). The "Forte" designation typically indicates a higher concentration or titer of specific antibodies compared to standard formulations. It is indicated for both the prevention of distemper in dogs following known or suspected exposure and as a therapeutic adjunct during the early stages of the disease to mitigate clinical symptoms and improve survival outcomes.

Brand names
Canglob D Forte
Other names
Canine distemper hyperimmune serumImmunoglobulinum anti febris contagiosae canis
02

Targets

CDV (Canine distemper virus)

Beyond the preview

Go deeper on Canglob D Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canglob D Forte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call